Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laptook, A. R.
Right arrow Articles by Nunnally, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laptook, A. R.
Right arrow Articles by Nunnally, R. L.
NEUROLOGY 1989;39:709
© 1989 American Academy of Neurology

Use of 31P magnetic resonance spectroscopy to characterize evolving brain damage after perinatal asphyxia

A. R. Laptook, MD, R.J.T. Corbett, PhD, R. Uauy, MD, PhD, C. Mize, MD, PhD, D. Mendelsohn, MD and R. L. Nunnally, PhD

Departments of Pediatrics and Radiology, University of Texas Southwestern Medical Center, Dallas, TX.

We investigated postasphyxial brain damage with 31P magnetic resonance spectroscopy (MRS) and correlated it with neurologic assessment and standard laboratory evaluation during the first 10 months of life in 1 infant, baby G. We compared these observations to 31P MRS data from 7 healthy term newborns, 1 normal infant examined serially over the first 8.5 months of life, and 5 other term infants following perinatal asphyxia. MRS noninvasively provides biochemical correlates of the evolution of brain damage following perinatal asphyxia and suggests that pH derived from the inorganic phosphate peak may serve as a marker for brain injury.

Address correspondence and reprint requests to Dr. Laptook, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235-9063.

Supported by funding from Diasonica, Inc. and the National Institutes of Health Southwest In Vivo Resource Facility under grant P41 RR02584. Fellowship support for Ronald Corbett was provided by the Medical Research Council of Canads and the Department of Pediatrics.

Received May 24, 1988. Accepted for publication in final form November 2, 1988.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.